Cargando…

Comprehensive analysis of T cell receptor repertoire in patients with KRAS mutant non-small cell lung cancer

BACKGROUND: Kirsten rat sarcoma viral oncogene homolog (KRAS) is one of the most frequently mutated oncogenes in non-small cell lung cancer (NSCLC). The administration of immunotherapy has demonstrated significant efficacy in prolonging the overall survival of patients with KRAS mutation in recent y...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yadong, Peng, Ling, Zhao, Ming, Xiong, Yuanyuan, Xue, Jianchao, Li, Bowen, Huang, Zhicheng, Liu, Xinyu, Yang, Xiaoying, Song, Yang, Bing, Zhongxing, Guo, Chao, Tian, Zhenhuan, Gao, Chao, Cao, Lei, Cao, Zhili, Li, Ji, Jiang, Xu, Si, Xiaoyan, Zhang, Li, Li, Xiaoguang, Zheng, Zhibo, Song, Mengmeng, Chen, Rongrong, Lim, Wan-Teck, Pavan, Alberto, Romero, Atocha, Liang, Naixin, Yang, Huaxia, Li, Shanqing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554687/ https://www.ncbi.nlm.nih.gov/pubmed/36248331 http://dx.doi.org/10.21037/tlcr-22-629

Ejemplares similares

Characteristics of T-Cell Receptor Repertoire and Correlation With EGFR Mutations in All Stages of Lung Cancer
por: Yang, Huaxia, et al.
Publicado: (2021)

Pathological complete response to neoadjuvant ceritinib of a crizotinib‐resistant, stage IIIB non‐small cell lung cancer with ALK rearrangement: A case report
por: Bing, Zhongxing, et al.
Publicado: (2021)

Footprints: Stamping hallmarks of lung cancer with patient-derived models, from molecular mechanisms to clinical translation
por: Song, Yang, et al.
Publicado: (2023)

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitor Combination Therapy as First-Line Treatment for Patients with Advanced EGFR-Mutated, Non-Small Cell Lung Cancer: A Systematic Review and Bayesian Network Meta-Analysis
por: Xue, Jianchao, et al.
Publicado: (2022)

Survival and prognostic factors of lung cancer patients with preexisting connective tissue disease: a retrospective cohort study
por: Yang, Huaxia, et al.
Publicado: (2020)

Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer
por: Liang, Naixin, et al.
Publicado: (2022)

Long noncoding RNA MALAT-1 is a novel inflammatory regulator in human systemic lupus erythematosus
por: Yang, Huaxia, et al.
Publicado: (2017)

DNA methylation patterns at and beyond the histological margin of early-stage invasive lung adenocarcinoma radiologically manifested as pure ground-glass opacity
por: Jia, Ziqi, et al.
Publicado: (2021)

Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell Lung Cancer Patients
por: Cao, Lei, et al.
Publicado: (2022)

Fatal Tumour Lysis Syndrome Induced by Brigatinib in a Lung Adenocarcinoma Patient Treated With Sequential ALK Inhibitors: A Case Report
por: Wang, Yadong, et al.
Publicado: (2021)

Temozolomide encapsulated and folic acid decorated chitosan nanoparticles for lung tumor targeting: improving therapeutic efficacy both in vitro and in vivo
por: Li, Kaidi, et al.
Publicado: (2017)

肺微小脑膜上皮样结节——认知进展与争论
por: LI, Haochen, et al.
Publicado: (2023)

Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
por: Song, Yang, et al.
Publicado: (2020)

Machine Learning-Assisted Dual-Marker Detection in Serum Small Extracellular Vesicles for the Diagnosis and Prognosis Prediction of Non-Small Cell Lung Cancer
por: Li, Wenzhe, et al.
Publicado: (2022)

First-line treatment selection with organoids of an EGFRm + TP53m stage IA1 patient with early metastatic recurrence after radical surgery and follow-up
por: Jia, Ziqi, et al.
Publicado: (2020)

KLF8 overexpression promotes the growth of human lung cancer cells by promoting the expression of JMJD2A
por: Ma, Dongjie, et al.
Publicado: (2019)

Efficient isolation and quantification of circulating tumor cells in non-small cell lung cancer patients using peptide-functionalized magnetic nanoparticles
por: Liang, Naixin, et al.
Publicado: (2020)

Determining EGFR-TKI sensitivity of G719X and other uncommon EGFR mutations in non-small cell lung cancer: Perplexity and solution
por: Li, Kaidi, et al.
Publicado: (2017)

USP5 knockdown alleviates lung cancer progression via activating PARP1-mediated mTOR signaling pathway
por: Cao, Lei, et al.
Publicado: (2023)

The action mechanism of lncRNA-HOTAIR on the drug resistance of non-small cell lung cancer by regulating Wnt signaling pathway
por: Guo, Feng, et al.
Publicado: (2018)

HER2 transmembrane domain mutation: comprehensive characteristics and real-world evidence of treatment response in Chinese lung adenocarcinoma
por: Jia, Ziqi, et al.
Publicado: (2021)

TRUST4: immune repertoire reconstruction from bulk and single-cell RNA-seq data
por: Song, Li, et al.
Publicado: (2021)

Mature Red Blood Cells Contain Long DNA Fragments and Could Acquire DNA from Lung Cancer Tissue
por: Liang, Naixin, et al.
Publicado: (2023)

Safety and Efficacy of the Rechallenge of Immune Checkpoint Inhibitors After Immune-Related Adverse Events in Patients With Cancer: A Systemic Review and Meta-Analysis
por: Zhao, Qing, et al.
Publicado: (2021)

MicroRNA-539 Inhibits the Epithelial–Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4
por: Cao, Zhili, et al.
Publicado: (2018)

Retraction notice to “MicroRNA-539 Inhibits the Epithelial-Mesenchymal Transition of Esophageal Cancer Cells by Twist-Related Protein 1-Mediated Modulation of Melanoma-Associated Antigen A4” [Oncology Research 26(4) (2018) 529-536]
por: Cao, Zhili, et al.
Publicado: (2021)

Survival outcomes of surgery in patients with pulmonary large-cell neuroendocrine carcinoma: a retrospective single-institution analysis and literature review
por: Chen, Yeye, et al.
Publicado: (2021)

Are immune-related adverse events associated with the efficacy of immune checkpoint inhibitors in patients with cancer? A systematic review and meta-analysis
por: Zhou, Xiaoxiang, et al.
Publicado: (2020)

Molecular genetic studies on EGFR, KRAS, BRAF, ALK, PIK3CA, PDGFRA, and DDR2 in primary pulmonary adenoid cystic carcinoma
por: Huo, Zhen, et al.
Publicado: (2015)

NRAS and KRAS polymorphisms are not associated with hepatoblastoma susceptibility in Chinese children
por: Yang, Tianyou, et al.
Publicado: (2019)

Continuous Hemofiltration Reduces Mortality in Severe Acute Pancreatitis: A Meta-Analysis
por: Guo, Yulin, et al.
Publicado: (2020)

T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures
por: Xu, Jing, et al.
Publicado: (2023)

Patients with ectopic ACTH syndrome might have a better prognosis in bronchopulmonary carcinoids with lymph node metastasis received radical surgery: a single-centre retrospective study in the last 22 years in China
por: Gao, Chao, et al.
Publicado: (2022)

TCR repertoire landscape reveals macrophage-mediated clone deletion in endotoxin tolerance
por: Zhao, Juanjuan, et al.
Publicado: (2023)

Transcriptomic and Mutational Analysis Discovering Distinct Molecular Characteristics Among Chinese Thymic Epithelial Tumor Patients
por: Liang, Naixin, et al.
Publicado: (2021)

Comprehensive genomic profiling aids in understanding the lesion origins of a patient with six synchronous invasive lung adenocarcinomas: a case study
por: Song, Yang, et al.
Publicado: (2020)

KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese Patients
por: Wang, Shuhang, et al.
Publicado: (2022)

CNTs Intercalated LDH Composite Membrane for Water Purification with High Permeance
por: Li, Qian, et al.
Publicado: (2021)

Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer
por: Yang, Kaixin, et al.
Publicado: (2022)

Small molecular inhibitors for KRAS-mutant cancers
por: Wu, Xuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s2v74p64pq8ikk30rn2rr8crom